SDC 3: Time until virologic suppression and failure

Slides:

Advertisements

Similar presentations

Paediatric Language Group

Advertisements

European Guidelines for the HIV Treatment Esteban Martínez Infectious Diseases Unit Hospital Clínic University of Barcelona Barcelona SPAIN.

Children Aged 5 to

HIV antibody detection in children who started antiretroviral treatment in infancy Louise Kuhn, Diana Schramm, Stephanie Shiau, Renate Strehlau, Maria.

Primary Healthcare Facilities Deliver More Effective Antiretroviral Therapy: An Evaluation in Four Provinces in South Africa Geoffrey Fatti, Ashraf Grimwood.

HIV and AIDS Data Hub for Asia-Pacific Review in slides Children Last updated: February 2015.

BHIVA 2006 Gus Cairns. BHIVA 2006 – selected studies People with CD4s

HIV and AIDS Data Hub for Asia-Pacific Review in slides Treatment Last updated: December 2014.

BHIVA Clinical Audit Management of patients who switch therapy; re-audit of patients starting therapy from naïve.

Switch to ATV/r + 3TC  SALT Study. ATV/r 300/100 mg qd + 2 NRTI (investigator-selected) N = 143 ATV/r 300/100 mg + 3TC 300 mg qd  Design Randomisation*

The Immunologic Efficacy of Antiretroviral Therapy among HIV-infected Patients in North America and Africa Elvin Geng* 1, Eric Vittinghoff 1, Jean Nachega.

The Role of Maraviroc in Antiretroviral Therapy for Treatment-Experienced Patients Daniel R. Kuritzkes, MD Section of Retroviral Therapeutics Brigham and.

BHIVA Clinical Audit Management of patients who switch therapy; re-audit of patients starting therapy from naïve.

Switch to LPV/r monotherapy  Pilot LPV/r  M  LPV/r Mono  KalMo  OK  OK04  KALESOLO  MOST  HIV-NAT 077.

Switch to ATV/r monotherapy  ATARITMO  Swedish Study  ACTG A5201  OREY  MODAt Study.

ZIMBABWE AIDS CARE FOUNDATION NEWLANDS CLINIC Virological Outcomes in Adult Patients on Second Line ART, at Newlands Clinic Dr S. Bote.

Good Three-year Outcomes of Antiretroviral Therapy at Multiple NGO- assisted facilities in Four Provinces in South Africa Geoffrey Fatti, Ashraf Grimwood.

The effect of tuberculosis treatment on virologic and immunologic response to combination antiretroviral therapy among South African children Heidi M.

Switch to DRV/r monotherapy  MONOI  MONET  PROTEA  DRV600.

02-15 INFC Substitution of raltegravir for ritonavir-boosted protease inhibitors in HIV-infected patients: The SPIRAL study* 1 Date of preparation:

Switch to LPV/r monotherapy  Pilot LPV/r  M  LPV/r Mono  KalMo  OK  OK04  KALESOLO  MOST  HIV-NAT 077.

Q1 Which of the following descriptions about HIV and TB interaction is right ? Which of the following descriptions about HIV and TB interaction is right.

WORLD AIDS DAY Zero new HIV infections Zero discrimination Zero AIDS-related deaths.

HIV/AIDS By: Shawn Dye

Scaling up access to HIV treatment: comparing outcomes among children receiving treatment at mobile and hospital-based HIV clinics in rural Zambia Janneke.

MDG 6: Combat HIV/AIDS and other diseases. Where are we…  Regionally, “on track” for MDG-6 (only a few countries are progressing slowly or show no progress)

Strategies for Management of Antiretroviral Therapy Study Wafaa El-Sadr and James Neaton for the SMART Study Team.

N ORTHWEST A IDS E DUCATION AND T RAINING C ENTER Major Changes to the HHS Adult and Adolescent HIV Treatment Guidelines: April 2015 Brian R. Wood, MD.

Figure 1: Percentage change in the number of people dying from AIDS-related causes between 2005 and 2011 in countries with 100 or more AIDS-related deaths.

Figure 2: Trends in currently prescribed antiretroviral therapy % prescribed HAART increased from 74% to 83% Trends in ART use, HIV viral load, and CD4.

 Design Open-label years Chronic HCV infection Genotype 1 HCV RNA > 10,000 IU/mL HIV co-infection Stable ART* with HIV RNA < 50 c/mL ≥ 24 weeks.

Switch to ATV/r monotherapy  ATARITMO  Swedish Study  ACTG A5201  OREY  MODAt Study.

Date of download: 6/23/2016 From: The Anticipated Clinical and Economic Effects of 90–90–90 in South Africa Ann Intern Med. Published online May 31, 2016.

Fixed Dose Combination Anti-retroviral Drugs had Comparable Immunological, Virological and Adherence Potential with Single Drug Combinations Avong YK 1,

Loss to follow-up of HIV-infected women after delivery: The Swiss Mother and Child HIV Cohort Study Karoline Aebi-Popp, Roger Kouyos, Barbara Bertisch,

Dolutegravir plus Rilpivirine as Maintenance Dual Therapy SWORD-1 and SWORD- 2: Design

Title Factors associated with viral suppression among adolescents living with HIV in Cambodia “No conflicts of interest to declare”

A qualitative PCR minipool strategy to screen for virologic failure and antiretroviral drug resistance in South African patients on first-line antiretroviral.

ARV-trial.com Switch to ATV/r + 3TC ATLAS-M Study.

Table 1 Characteristics of study patients in survey of HIV infection in India. From: Natural History of Human Immunodeficiency Virus Disease in Southern.

ARV-trial.com Switch to LPV/r + RAL KITE Study 1.

From: Economic Savings Versus Health Losses: The Cost-Effectiveness of Generic Antiretroviral Therapy in the United States Ann Intern Med. 2013;158(2):84-92.

Dolutegravir versus Raltegravir in Treatment Experienced SAILING Study

Better Retention Rates Observed in Patients on Lopinavir than Atazanavir in Uganda

Only 23% of the survivors of RSE were normal at follow-up; 34% showed developmental deterioration and 36% developed new-onset epilepsy.230 Mortality is.

Children Last updated: April 2016.

Switch to DTG + 3TC ASPIRE Study.

Is Your Patient Engaged in Care

The role of CD4 in patient monitoring Amsterdam July 2018

Dorina Onoya1, Tembeka Sineke1, Alana Brennan1,2, Matt Fox1,2

Children Reliant on Benefits

Socioeconomic status and treatment outcomes for individuals with HIV on antiretroviral treatment in the UK: cross-sectional and longitudinal analyses

Trends in virological and clinical outcomes in individuals with HIV-1 infection and virological failure of drugs from three antiretroviral drug classes:

Experiences & outcomes of group psychotherapy as an antiretroviral adherence support intervention among young people failing ART at Newlands Clinic, Harare,

When to Start and What to Use

Volume 381, Issue 9875, Pages (April 2013)

Influence of possible intermediary variables on PR interval mean difference (95% CI) between HIV-infected (ART-naïve or ART-exposed) children and healthy.

Switch to RAL-containing regimen

Volume 377, Issue 9777, Pages (May 2011)

Costs of eliminating HIV in South Africa have been underestimated

Switch to ATV/r monotherapy

Switch to ATV/r monotherapy

ARV-trial.com Switch to ATV/r + RAL HARNESS Study 1.

Analytic framework illustrating exposure to preventive measures that reduce the risk of transmission between HIV-serodiscordant sex partners. Analytic.

Switch to LPV/r monotherapy

Human immunodeficiency virus-1 B and non-B subtypes with the same drug resistance pattern respond similarly to antiretroviral therapy M. Franzetti, M.

Share your thoughts on this presentation with #IAS2019

INTRODUCTION OBJECTIVES METHODS RESULTS DISCUSSION

The IAS TB/HIV Research Prizes are awarded to:

Presentation transcript:

SDC 3: Time until virologic suppression and failure Duration until subsequent virological failure Duration until first virological suppression N: 81 35 14 7 6 2 1 %: 100 57 84 92 94 97 100 N: 81 74 66 58 42 41 36 21 10 %: 100 91 85 80 63 62 60 57 51 ART: antiretroviral therapy; N: number of children; %: proportion of children